Hidradenitis Suppurativa (HS) Case study

Click here for a PDF version of this case study

AD case study

Innovation in dermatology research icon


Innovaderm successfully managed this HS study
and this resulted in:

Enrollment completed 3 months ahead of schedule


Study Characteristics

    • Study Phase: II
  • Patient Population: Hidradenitis Suppurativa
  • IP Route of Administration: Systemic - Subcutaneous
  • Site distribution: 25 in North America and 16 in Europe



Study Challenges and Solutions





Several screen failures (SF) due to late availability of lab results

    • Pro-active monitoring of lab results regarding patients’ eligibility by project team
    • Flagged alerts to individual sites and follow-up with central lab on unexpected delays

Outcome: Screenfailure rate reduced due to early identification of lab errors and lab patients’ tests adequately screened

Phone job interview


Transportation fees (i.e., couriers) especially for lab samples from countries outside European Union

    • Thorough assessment of cost drivers for shipment frequencies (sample stability and required turn-around time to obtain results)
    • Regrouping of shipments and modification to the lab panel to respect budgeted fees

Outcome: Significant reduction in shipping costs


Academic sites
Delay in start-up activities due to large proportion of academic sites in the study

    • Frequent, tailored 1:1 calls with PIs prior to study initiation
    • Site-centricity (i.e., involvement from onset of study)

Outcome: Early-stage discussions with PIs helped streamlined recruitment and start-up timelines


Key Success Factors & Strategies

Phone interview icon Optimal site selection: experienced PIs in HS and experienced Innovaderm sites

Site engagement Implemented broad reach digital ad campaigns / assisted sites with the development of recruitment material



Recruitment Curve


Enrollment completed 3 months ahead of schedule



Contact us


Get notified to have the latest trends and be at the forefront of dermatology clinical research and innovation.

Newsletter subscription resources

*By subscribing to our newsletter, you acknowledge and agree to the terms of our privacy policy.

Innovaderm Research Wave